BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2431249)

  • 1. [Lactic acidosis in non-Hodgkin's lymphoma].
    Navigante AH; Chacón RD
    Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
    Konopka L; Pawelski S
    J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
    Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
    [No Abstract]   [Full Text] [Related]  

  • 4. Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy.
    Osorio S; Bernis C; de La Cámara R
    Haematologica; 2002 Feb; 87(2):ELT05. PubMed ID: 11836182
    [No Abstract]   [Full Text] [Related]  

  • 5. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
    Cuthbert RJ; Craig JI; Ludlam CA
    Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956
    [No Abstract]   [Full Text] [Related]  

  • 6. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    Armitage JO
    N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Mross K
    N Engl J Med; 1995 Sep; 333(11):728; author reply 730. PubMed ID: 7637757
    [No Abstract]   [Full Text] [Related]  

  • 8. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
    Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
    Pittrová H; Koza V; Vozobulová V; Cetkovský P; Skopek P; Jungerová J; Cepelák V
    Vnitr Lek; 1989 Dec; 35(12):1177-82. PubMed ID: 2483776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.
    Gerhartz HH; Engelhard M; Brittinger G; Schlimok G; Thiel E; Huber C; Emmerich B; Schadek C; Brandmaier R; Stern AC
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of granulocyte colony-stimulating factor after chemotherapy with CHOP in patients with non-Hodgkin's lymphoma and HIV infection].
    Navarro JT; Ribera JM; Gómez-Espuch J; Feliu E
    Med Clin (Barc); 1996 Jun; 107(3):118-9. PubMed ID: 8754503
    [No Abstract]   [Full Text] [Related]  

  • 12. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
    Pawelski S; Konopka L; Pakulska J; Gutkowska J
    Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vibrio cholerae can be encountered even at home].
    Sinisalo M; Oksanen K; Koivisto V; Vikberg V
    Duodecim; 1991; 107(22):1880-3. PubMed ID: 1285425
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
    Basaran G; Basaran M; Onat H
    J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
    [No Abstract]   [Full Text] [Related]  

  • 15. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
    Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Machida U; Kami M; Hirai H
    N Engl J Med; 1998 Nov; 339(20):1475-6; author reply 1477. PubMed ID: 9841318
    [No Abstract]   [Full Text] [Related]  

  • 17. Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
    Sonneveld P; Hop W; Mulder AH; Michiels JJ; Blijham G; van de Lelie J; Raemakers JW; Nieuwenhuis K; van der Heul C
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):9-12. PubMed ID: 8073309
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma].
    Furukawa Y; Takagi S; Tsuboyama A; Tsunoda S; Akashi M; Komatsu N; Takeda K; Muroi K; Akutsu M; Ohsaka A
    Rinsho Ketsueki; 1987 Sep; 28(9):1544-52. PubMed ID: 3437516
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-Hodgkin's lymphoma presenting with cardiac tamponade.
    Gerardi DA; Hellman RM; Conlon M
    Conn Med; 1992 Jan; 56(1):11-3. PubMed ID: 1547630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of malignant non-Hodgkin's lymphoma in elderly patients.
    Michiels JJ
    Neth J Med; 1988 Feb; 32(1-2):50-1. PubMed ID: 3347326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.